Duration of dual antiplatelet therapy in patients with CKD and drug-eluting stents: a meta-analysis
Published inClinical Journal of the American Society of Nephrology, vol. 14, no. 6, p. 810-822
Publication date2019
Abstract
Keywords
- Drug-Eluting Stents
- Hemorrhage
- Incidence
- Myocardial Infarction
- Odds Ratio
- Randomized Controlled Trials as Topic
- Renal Insufficiency
- Chronic
- Risk
- Stroke
- All-cause mortality
- Chronic kidney disease
- Drug-eluting stents
- Major bleeding
- Myocardial infarction
- Thrombosis
Affiliation
Citation (ISO format)
MAVRAKANAS, Thomas A et al. Duration of dual antiplatelet therapy in patients with CKD and drug-eluting stents: a meta-analysis. In: Clinical Journal of the American Society of Nephrology, 2019, vol. 14, n° 6, p. 810–822. doi: 10.2215/CJN.12901018
Main files (1)
Article (Published version)
Identifiers
- PID : unige:143073
- DOI : 10.2215/CJN.12901018
- PMID : 31010936
Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556713/
ISSN of the journal1555-9041